TSX:KSI - Toronto Stock Exchange - CA4988241010 - Common Stock - Currency: CAD
Kneat achieves record revenue and gross profit in Q4 2024, with ARR growing 60% to $59.7 million....
Kneat will announce 2024 fourth-quarter and full-year financial results after market close on February 26, 2025....
ALTEN selects Kneat to digitize validation for itself and its customers....
Kneat announces voting results of 2024 Annual General Meeting of shareholders....
A large consumer packaged goods producer signed an agreement with Kneat to digitize validation in its life science division. ...
Leading European global therapeutics company more than 20,000 people selects Kneat to digitize its validation processes....
Kneat has signed a Master Services Agreement with a global provider of critical care products with over 50,000 employees....
Medical devices and healthcare therapies maker signs 3-year Master Services Agreement with Kneat to streamline its computer systems validation processes....
Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively, ...
Third-quarter Revenue and Gross Profit Growth Accelerate to 52% and 78% Respectively
Kneat signs a global and diverse medical devices manufacturer for digital validation....
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7...
Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million. ...
Another global pharmaceutical company selects Kneat to digitize its validation processes....
Kneat filed a final short-form prospectus, which qualifies the distribution of common shares in connection with its previously announced bought deal....
Real-life examples to help investors make sense of this critical document.
Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%...
Pharma technology leader enhances its portfolio by becoming a certified Kneat reseller, implementation and managed services partner ...
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com
Kneat maintains 35% year-over-year revenue growth to surpass $10 million quarterly revenue mark, as annual recurring revenue growth accelerates to 57%....
Kneat's Q4 and 2023 financial results show Annual Recurring Revenue up 55% year over year, to $37.4 million, and record gross margin of 72% in Q4....
Kneat announced the closing of its bought deal: it issued 6,153,880 common shares at $3.25 per share for gross proceeds of $20,000,110. ...
Kneat will announce its Q4 2023 results on February 21, 2024 after market close and host a call for investors the following morning. ...
The company has amended its agreement with a syndicate of investment dealers led by Cormark Securities, and will now sell 5.35M shares at $3.25 per share.
Kneat announces ~$15M bought deal public offering with underwriters led by Cormark Securities for growth, working capital, and general purposes.